loader
Please Wait
Applying Filters...
menu
    • menu

    Generics: Suboxone® (buprenorphine HCL & naloxone HCL):Indivior v. Dr. Reddy's Laboratories - Dr. Reddy\'s Laboratories

    MenuDr. Reddy's Laboratories

    Uploaded: 2022
    News
    Dr Reddy’s launches first-to-market generic Bosutinib in US

    15 Jun 2026

    // PRESS RELEASE

    Kunwar Khurana elevated to Head – Sales and Marketing

    09 Jun 2026

    // INDPHARMAPOST

    Dr Reddy's launches oral semaglutide biosimilar Obeda in India

    20 May 2026

    // ECONOMICTIMES

    DATA COMPILATION
    #PharmaFlow

    DRL VB RM

    Contact Supplier

    Website

    CPhI Korea

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years
    Xls

    CATEGORY PAGE
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100302
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.